 |
The Promise of Personalized MedicineAuthor: Perry Dimas
There is no personalized medicine without a diagnostic test to help in the process. The Promise of Personalized Medicine is a podcast that explores the process of creating more personalized medicine and the Medical Directors who ensure that the right care is being delivered to us all. Season 1 will focus on understanding best practices by using the Blueprint of Success format as a template for labs to use when trying to get their novel diagnostic test approved by health plans. This is The Promise of Personalized Medicine. Language: en-us Genres: Health & Fitness, Medicine Contact email: Get it Feed URL: Get it iTunes ID: Get it |
Listen Now...
Why Your Insurance Won't Pay for Prevention (Yet)
Episode 9
Tuesday, 11 August, 2026
In this episode, host Perry Dimas sits down with Dr. Michelle Malcolmson — a physician trained at the intersection of biology, nutrition, and genetics — to unpack what personalized medicine really means and why the healthcare system still struggles to deliver it.Dr. Malcolmson defines precision medicine as treating the individual rather than the "population average," and explains how falling costs of genetic testing now make it possible to understand a patient's pharmacogenomics (how they metabolize drugs), polygenic risk, and disease susceptibility years before symptoms appear. She and Perry dig into why insurance coverage for these tests lags so far behind the science — tracing the problem back to a payment system where private insurers cover people's "healthy years" while Medicare absorbs the cost of their "sick years," leaving little financial incentive for prevention.The conversation ranges across:Why it took over a decade for prediabetes guidelines to catch up to the evidenceThe disconnect between short-term insurance enrollment (patients often switch plans every few years) and the long-term payoff of preventive careHow oncology has led the way in genetic-guided treatment, and what other specialties can learn from itStrategic advice for diagnostic and biotech companies: focus on Medicare reimbursement pathways rather than chasing employer groups firstThe added complexity Medicare Advantage plans bring to prior authorizations and accessWhy patients may need to become the "CEO of their own health" — tracking labs, genetics, body composition, and grip strength — while the system slowly realigns its incentivesThe episode closes with a shared vision: shrinking the gap between lifespan and healthspan, and empowering individuals to advocate for their own preventive care even before the payer system catches up.—-------Stay connected with our host, Perry Dimas, here on LinkedIn! 📧 Interested in joining our medical director advisory group? Email us at info@accessdx.com 🔗 Connect on LinkedIn: linkedin.com/company/accessdx
